Hedvig NordengHedvig Nordeng, M.ScPharm, Dr.philos. is a professor and head of the Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (Ui0), Norway. Professor Nordeng’s research experience and expertise lie within perinatal pharmacoepidemiology and pharmacotherapy during pregnancy and breastfeeding. She has a long track record of interdisciplinary research and of international research projects, using large population-based cohorts and linked healthcare registries, especially in the Nordic countries. She was awarded an ERC StG for the project “DrugsInPregnancy” and is currently the head of an International Partnerships for Excellent Education, Research and Innovation on genetic pharmacoepidemiology (iAPOGEE) and head of the UiOLifeScience convergence environment UIORealArt: Real world – artificial worlds: Improving causal inference in perinatal pharmaco-epidemiology using machine learning approaches on real-world and artificial data. Dr. Nordeng has authored over 200 scientific articles, book chapters and clinical guidelines. In 2017 she was awarded the Titan prize for excellence in science dissemination by the UiO. As of 2018, she has been an EU commission appointed independent scientific expert member of PRAC, European Medicines Agency. She is a member of NorPEN (Nordic Pharmacoepidemiology Network) and a fellow of the International Society of Pharmacoepidemiology (FISPE). Read more about her research here: www.mn.uio.no/farmasi/english/research/groups/pharma-safe/index.html